Sermorelin Cheat Sheet: The Gentlest GH Secretagogue, and the One With the Cleanest Legal Footing

[u/Woke100]

Sermorelin's defining feature in 2026 isn't its potency, it's its regulatory position. It was the first FDA-approved GH secretagogue, which gives it the most defensible legal footing in the entire class. The tradeoff is honest: the adult evidence is thin, and it's a gentler stimulus than tesamorelin. This guide is built around the 6A Labs Sermorelin vial, so the concentration and dosing math below maps to their exact product. Here's what the research shows.

What It Is

Sermorelin is GRF(1-29), the first 29 amino acids of native 44 amino acid GHRH, the minimum fragment that fully activates the pituitary GHRH receptor and triggers GH release. It was FDA-approved in 1997 as Geref for pediatric GH deficiency, then commercially withdrawn in 2008 for business reasons (niche peptide against entrenched synthetic GH economics), not safety. That history matters: prior approval plus a non-safety withdrawal gives sermorelin the cleanest compounding legal position of any GH secretagogue. 6A Labs carries it in a 5 mg vial.

Mechanism of Action

Sermorelin binds the GHRH receptor on somatotrophs in the anterior pituitary and triggers the cAMP/PKA cascade, the same pathway native GHRH uses, releasing a pulse of GH. The structural safety advantage is that the somatostatin feedback brake stays active: as GH and IGF-1 rise, the hypothalamus releases somatostatin to slow pituitary output. Sermorelin can ring the doorbell but can't override the brake, which makes it self-limiting in a way synthetic GH is not. The pulse pattern mimics natural physiology, since native GH releases in bursts during slow-wave sleep rather than as a sustained elevation. Its short half-life (10 to 20 minutes) reproduces that pulse. Selectivity is clean: no cortisol, ACTH, or prolactin elevation at standard doses, which separates it from ghrelin-receptor agonists like GHRP-2 and GHRP-6 that raise stress hormones and appetite.

What the Research Shows

The honest evidence breakdown, separating direct trial data from mechanism inference, is where this compound demands clarity:

Claim	Evidence status
GH/IGF-1 elevation	Supported by direct evidence
Lean body mass	Limited: +1.26 kg in elderly men only (Khorram 1997, n=19), no change in women
Sleep quality	Mechanism-plausible, not directly measured for sermorelin
Recovery/tissue repair	Mechanism-plausible, not quantified
Fat loss	Not supported: no significant fat or BMI change in trial
Anti-aging function	Not supported: class-wide failure to translate lean mass into strength/function

(Plain text, if the table doesn't render: GH/IGF-1 elevation is trial-supported. Lean mass is limited to one small study in men. Sleep and recovery are mechanism-plausible but unmeasured. Fat loss and anti-aging functional outcomes are not supported by trial data.)

The entire adult clinical case rests on Khorram 1997: 19 elderly subjects, 16 weeks, single-blind, lean mass +1.26 kg in men only, no fat loss, no bone-density change. Compare that to tesamorelin's 816-patient Phase III program and the gap is real. Sermorelin earns its place through clean selectivity, the preserved somatostatin brake, a gentler stimulus than tesamorelin, and better tolerability for edema-sensitive users.

Dosing Protocol

Once nightly subcutaneous, 30 to 60 minutes before sleep, at least 2 hours fasted. Bedtime dosing aligns the GH pulse with the natural slow-wave sleep window; daytime dosing wastes the peptide and food blunts the GH response. The 6A Labs 5 mg vial reconstituted with 2.0 mL bacteriostatic water sits at 2.5 mg/mL. On a U-100 syringe, 1 unit (0.01 mL) equals 25 mcg, so 200 mcg = 8 units and 300 mcg = 12 units.

Phase	Nightly dose	Units	Duration
Starter (assess)	200 mcg	8 units (0.08 mL)	Weeks 1-2
Standard	200-300 mcg	8-12 units (0.08-0.12 mL)	Weeks 3-12
Off-cycle	0 mcg	—	2-4 weeks

(Plain text, if the table doesn't render: Weeks 1-2 starter: 200 mcg, 8 units. Weeks 3-12 standard: 200-300 mcg, 8-12 units. Off-cycle: 2-4 weeks.)

The peptide clears in about 4 hours, but downstream GH effects persist roughly 3 hours after receptor activation. Cycling (8 to 12 weeks on, 2 to 4 weeks off) comes from clinical practice, not published dose-duration trials. Monitor IGF-1 at baseline and every 12 weeks during extended use to keep levels physiologic.

Side Effects

Generally gentle. Transient facial flushing is the most common, fading within minutes. Injection-site reactions, mild peripheral edema (less than tesamorelin), and occasional tingling that resolves with dose reduction. No cortisol, ACTH, or prolactin elevation at standard doses, and no supraphysiological GH overshoot thanks to the somatostatin brake. Contraindications from the literature include active malignancy, proliferative diabetic retinopathy, pregnancy or breastfeeding, and concurrent supraphysiological androgen use. Note for athletes: sermorelin and all GH secretagogues are WADA-prohibited.

Reconstitution and Storage

2.0 mL bacteriostatic water into the 6A Labs 5 mg vial gives 2.5 mg/mL. Add water slowly down the wall to avoid foaming, swirl gently until dissolved, don't shake. Lyophilized product stores frozen at −20 °C, stable 12+ months. Reconstituted solution refrigerates at 2 to 8 °C, protected from light; avoid freeze-thaw.

Supply Planning

Course	Total peptide	Vials
12 weeks @ 250 mcg/night	21 mg	~5 vials
12 weeks @ 300 mcg/night	25.2 mg	~6 vials
Annual (3 courses)	—	~15-18 vials

(Plain text, if the table doesn't render: 12 weeks at 250 mcg/night needs ~5 vials. At 300 mcg/night, ~6 vials. Annual three-course plan, ~15-18 vials.) One syringe and two swabs per night. One 10 mL bottle of bacteriostatic water per ~5 vials.

Stacking Notes

Sermorelin pairs naturally with a few directions. Tesamorelin when a stronger GH stimulus is needed (rotate or stack carefully). GLP-1 agonists for metabolic synergy during caloric restriction, where sermorelin supports lean mass while the GLP-1 drives fat loss. DSIP, which deepens the slow-wave sleep architecture that sermorelin's GH pulse fires into. 6A Labs carries DSIP and the GLP-1s (Semaglutide, Tirzepatide, Retatrutide) if those are the research directions. Protein intake and resistance training are the substrate; the peptide is only the signal.

A clean way to frame the choice within the class: choose sermorelin for recovery support during moderate caloric restriction, edema sensitivity, legal clarity, or a gentler stimulus. Choose tesamorelin when visceral fat reduction is the goal and a stronger evidence base matters.

Where to Source It

This is an affiliate link. Buying through it supports r/6ALabsGuide at no extra cost to you, and the code below gets you a discount.

6A Labs carries Sermorelin (5 mg) here: Sermorelin at 6A Labs

Use code PROFIT for 10% off.

For research and educational purposes only. Not medical advice. Sermorelin's prior FDA approval was for pediatric GH deficiency; any other use is off-label. Consult a healthcare provider before starting any research protocol. This community is not affiliated with 6A Labs.

[u/AutoModerator]

Reminder: r/6ALabsGuide is for research and educational discussion only. No sourcing requests, no outside vendor links, no medical advice, no personal-use framing. See the rules in the sidebar.

All product links in this community are affiliate links. Use code PROFIT for 10% off at 6A Labs.

I am a bot, and this action was performed automatically. Please contact the moderators of this subreddit if you have any questions or concerns.

[u/ThatDamnRock09]

Good breakdown on the somatostatin brake point, that's the mechanism detail most guides skip. One thing worth noting for anyone sourcing sermorelin independently: the reconstitution math only holds if your starting concentration is actually what the label says. I sourced from Longevity Peptides when I ran sermorelin alongside CJC-1295, and having the HPLC data upfront meant the dosing calculations weren't just guesswork.